tiprankstipranks
Vivos Therapeutics (VVOS)
NASDAQ:VVOS
US Market

Vivos Therapeutics (VVOS) Cash flow

150 Followers

Vivos Therapeutics Cash Flow

VVOS's free cash flow for Q3 2023 was $-2.95M. For the 2023 fiscal year, VVOS's free cash flow was decreased by $-2.39M and operating cash flow was $-2.80M. See a summary of the company’s cash flow.
Cash Flow
TTM
Dec 22Dec 21Dec 20Dec 19Dec 18
Operating Cash Flow
$ -12.20M$ -19.60M$ -15.73M$ -5.68M$ -5.34M$ -5.31M
Investing Cash Flow
$ -888.00K$ -924.00K$ -2.61M$ -120.00K$ 86.22K$ -1.12M
Financing Cash Flow
$ 7.36M-$ 24.17M$ 23.54M$ 4.47M$ 5.25M
Cash Flow From Discontinued Operation
------
Other Cash Adjustment Inside Changein Cash
------
End Cash Position
$ 15.52M$ 3.52M$ 24.03M$ 18.21M$ 469.35K$ 1.25M
Income Tax Paid Supplemental Data
---$ 0.00$ 0.00$ 0.00
Interest Paid Supplemental Data
-$ 2.00K$ 18.00K$ 33.00K$ 20.67K$ 25.93K
Issuance Of Capital Stock
$ 8.00M-$ 27.93M$ 24.74M$ 1.25M$ 6.35M
Issuance Of Debt
--$ -25.00K$ 1.26M$ 3.76M$ 0.00
Repayment Of Debt
--$ -25.00K$ -75.00K$ -29.26K$ -88.24K
Free Cash Flow
$ -13.09M$ -20.52M$ -18.13M$ -5.80M$ -5.52M$ -6.56M
Domestic Sales
------
Foreign Sales
------
Currency in USD

Vivos Therapeutics Cash Flow

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis